洞察市场格局
解锁药品研发情报

客服电话

400-9696-311
医药数据查询

首页 临床进展 Hemorrhoid Treatment with injection of n-butyl-2-cyanoacrylate substance and its results: A Single Center Retrospective Study

【ChiCTR2100046170】Hemorrhoid Treatment with injection of n-butyl-2-cyanoacrylate substance and its results: A Single Center Retrospective Study

查看原文
立即下载
基本信息
登记号

ChiCTR2100046170

试验状态

正在进行

药物名称

/

药物类型

/

规范名称

/

首次公示信息日的期

2021-05-08

临床申请受理号

/

靶点

/

适应症

hemoroid

试验通俗题目

Hemorrhoid Treatment with injection of n-butyl-2-cyanoacrylate substance and its results: A Single Center Retrospective Study

试验专业题目

Hemorrhoid Treatment with injection of n-butyl-2-cyanoacrylate substance and its results: A Single Center Retrospective Study

申办单位信息
申请人联系人
请登录查看
申请人名称
请登录查看
联系人邮箱
请登录查看
联系人邮编

联系人通讯地址
请登录查看
临床试验信息
试验目的

we believe that n-butyl-2-cyanoacrylate material can be an alternative method to surgical methods that can be applied in hemorrhoids with future studies. We think that this procedure, which can be performed easily and effectively in outpatient clinic conditions, will be an easy method that can be applied to patients who need surgery but are afraid of surgery.

试验分类
请登录查看
试验类型

连续入组

试验分期

Ⅰ期

随机化

Between January 2012 and December 2020, n-butyl-2-cyanoacrylate was administered to 14 patients out of 127 patients who underwent hemorrhoidectomy. 4 of our patients were women and 10 were men. The average age of women was 49.25 and the average age of men was 43.7.

盲法

N/A

试验项目经费来源

Kafkas University

试验范围

/

目标入组人数

14

实际入组人数

/

第一例入组时间

2021-05-07

试验终止时间

1990-01-01

是否属于一致性

/

入选标准

grade 3 hemoroids；

排除标准

No；

研究者信息
研究负责人姓名
请登录查看
试验机构

Kafkas University

研究负责人电话
请登录查看
研究负责人邮箱
请登录查看
研究负责人邮编

/

联系人通讯地址
请登录查看
更多信息
获取更多临床信息查看权限
立即前往摩熵医药企业版免费查询
示例数据
<END>

Kafkas University的其他临床试验

更多

土耳其kafkas university general surgery的其他临床试验

更多

最新临床资讯

更多
摩熵医药企业版
50亿+条医药数据随时查
7天免费试用
体验产品